Some evidence points towards downstream insulin signalling defects as causal factors leading to skeletal muscle insulin resistance, which occurs independently of obesity and which are distinct from those observed in type 2 diabetes (Dunaif et al. 1992, 2001, Corbould 2008, Højlund et al. 2008). Here, INS is linked to type 2 diabetes mellitus.